Answers are grounded in this paper and cite their sources.
Technical improvements in head and neck cancer radiotherapy over the last decade have resulted in substantial reductions in dose to organs-at-risk. For a mix of tumors, we saw less xerostomia moving from 3D-conformal to more advanced techniques. For oropharynx-only there were additional improvements, including in global quality-of-life and sticky saliva.
No takes yet. Share an insight, caveat, or question.
Dahele et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: